National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 9/17/2021 release of VAERS data:

Found 4,589 cases where Vaccine is COVID19 and Manufacturer is MODERNA and Symptom is Cerebral venous sinus thrombosis or Cerebral venous thrombosis or Coagulopathy or Deep vein thrombosis or Disseminated intravascular coagulation or Embolism or Idiopathic thrombocytopenic purpura or Immune thrombocytopenia or Immune thrombocytopenic purpura or Ischaemic stroke or Myocardial infarction or Petechiae or Pulmonary embolism or Purpura or Thrombocytopenia or Thrombosis or Vasculitis



Case Details

This is page 10 out of 459

Result pages: prev   1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19   next


VAERS ID: 979630 (history)  
Form: Version 2.0  
Age: 46.0  
Sex: Female  
Location: New Jersey  
Vaccinated:2021-01-11
Onset:2021-01-15
   Days after vaccination:4
Submitted: 0000-00-00
Entered: 2021-01-27
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 012L20A / 1 LA / IM

Administered by: Public       Purchased by: ?
Symptoms: Blood test, Computerised tomogram, Pulmonary embolism, Thrombosis, Ultrasound Doppler, Ventilation/perfusion scan
SMQs:, Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Embolic and thrombotic events, venous (narrow), Thrombophlebitis (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 3 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: atenelol 25 mg, topiramate, singulair 10mg
Current Illness: n/a
Preexisting Conditions: svt, sleep apnea, asthma
Allergies: eletriptan, cantaloupe, cats
Diagnostic Lab Data: doppler, ct,vq scan, blood tests
CDC Split Type:

Write-up: blood clot in lungs, PE,


VAERS ID: 979773 (history)  
Form: Version 2.0  
Age: 75.0  
Sex: Female  
Location: Texas  
Vaccinated:2020-12-30
Onset:2021-01-16
   Days after vaccination:17
Submitted: 0000-00-00
Entered: 2021-01-27
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 025L20A / 1 RA / IM

Administered by: Senior Living       Purchased by: ?
Symptoms: Death, Pulmonary embolism
SMQs:, Embolic and thrombotic events, venous (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-01-16
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: none as far as i know
Current Illness: none per care giver
Preexisting Conditions: none that was reported
Allergies: none reported
Diagnostic Lab Data: none that i know of
CDC Split Type:

Write-up: Not sure if it has to do with the COVID vaccine but her caregiver reported to me today (1/27/20201) that she passed away on 01/16/2021 from a pulmonary embolism that was 18 days after vaccine


VAERS ID: 981912 (history)  
Form: Version 2.0  
Age: 67.0  
Sex: Female  
Location: California  
Vaccinated:2021-01-23
Onset:2021-01-23
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-01-28
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA UNKNOWN / 2 UN / IM

Administered by: Unknown       Purchased by: ?
Symptoms: Angiogram pulmonary abnormal, Cardiac arrest, Chest pain, Cold sweat, Death, Endotracheal intubation, Hypotension, Laboratory test, Pallor, Pulmonary embolism
SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (broad), Angioedema (broad), Neuroleptic malignant syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Embolic and thrombotic events, venous (narrow), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad), Hypotonic-hyporesponsive episode (broad), Respiratory failure (broad), Hypoglycaemia (broad), Dehydration (broad), Hypokalaemia (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-01-27
   Days after onset: 4
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: albuterol, fluticasone nasal spray, hydrochlorothiazide, losartan
Current Illness:
Preexisting Conditions: hypertension
Allergies: none
Diagnostic Lab Data: 1/27 in the ED patient underwent a CTA chest to reveal PE, basic labs, alteplase 100 mg, amiodarone 150 mg followed by infusion, was intubated with rocuronium, and placed on a norepinephrine drip.
CDC Split Type:

Write-up: Patient presented to the Emergency Department complaining of chest pain, pale, cool diaphoretic, and hypotensive. The patient was discovered to have a large saddle pulmonary embolism, went into cardiac arrest and expired. Of note, the patient received her second Moderna COVID vaccine on 1/23, which would place her first one approximately 12/25 if she received them at the appropriate interval. This information is from the patient''s daughter and the ED record, the information is not available in CAIR. Per the daughter, the patient started feeling ill on 1/21, improved on 1/25, and then acutely worsened on 1/27, resulting in the ED visit.


VAERS ID: 981928 (history)  
Form: Version 2.0  
Age: 51.0  
Sex: Female  
Location: Puerto Rico  
Vaccinated:2021-01-08
Onset:2021-01-09
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-01-28
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA - / 1 UN / IM

Administered by: Other       Purchased by: ?
Symptoms: Activated partial thromboplastin time prolonged, Acute kidney injury, Alanine aminotransferase increased, Albumin globulin ratio decreased, Amylase normal, Anion gap increased, Aspartate aminotransferase increased, Basophil count increased, Basophil percentage, Blood albumin normal, Blood alkaline phosphatase increased, Blood bilirubin increased, Blood calcium decreased, Blood chloride normal, Blood cholesterol normal, Blood creatine increased, Blood creatinine increased, Blood glucose increased, Blood lactate dehydrogenase increased, Blood osmolarity increased, Blood potassium decreased, Blood smear test abnormal, Blood sodium normal, Blood urea increased, Carbon dioxide decreased, Disseminated intravascular coagulation, Eosinophil count decreased, Eosinophil percentage decreased, Gamma-glutamyltransferase increased, Globulin, Glomerular filtration rate decreased, Haematocrit decreased, Haemoglobin decreased, Hypoglycaemia, Immature granulocyte count increased, International normalised ratio increased, Lipase normal, Lymphocyte count decreased, Lymphocyte percentage decreased, Mean cell haemoglobin increased, Mean cell volume increased, Mean platelet volume normal, Mechanical ventilation, Monocyte count normal, Monocyte percentage decreased, Neutrophil count increased, Neutrophil percentage increased, Pancreatitis acute, Platelet count decreased, Pneumonia, Protein total decreased, Prothrombin time prolonged, Red blood cell count decreased, Red blood cell nucleated morphology, Red cell distribution width increased, Respiratory failure, Sepsis, White blood cell count increased
SMQs:, Rhabdomyolysis/myopathy (broad), Acute renal failure (narrow), Liver related investigations, signs and symptoms (narrow), Liver-related coagulation and bleeding disturbances (narrow), Anaphylactic reaction (broad), Acute pancreatitis (narrow), Haematopoietic erythropenia (narrow), Haematopoietic leukopenia (narrow), Haematopoietic thrombocytopenia (narrow), Lactic acidosis (broad), Haemorrhage terms (excl laboratory terms) (narrow), Haemorrhage laboratory terms (broad), Hyperglycaemia/new onset diabetes mellitus (narrow), Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (broad), Retroperitoneal fibrosis (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (broad), Torsade de pointes, shock-associated conditions (broad), Hypovolaemic shock conditions (broad), Toxic-septic shock conditions (broad), Anaphylactic/anaphylactoid shock conditions (broad), Hypoglycaemic and neurogenic shock conditions (broad), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Acute central respiratory depression (narrow), Biliary system related investigations, signs and symptoms (narrow), Guillain-Barre syndrome (broad), Eosinophilic pneumonia (broad), Chronic kidney disease (broad), Hypersensitivity (broad), Tumour lysis syndrome (narrow), Respiratory failure (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (narrow), Infective pneumonia (narrow), Dehydration (broad), Hypokalaemia (narrow), Sepsis (narrow), Opportunistic infections (broad)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Benadryl 50mg PO HS, Duloxetine 30mg POD, Folic Acid 1mg POD, Gabapentin 300mg POD, Gemfibrozil 600mg POD, methotrexate 2.5mg PO weekly, Prednisone 5mg POD, Propranolol 80mg POD, Sulfasalazine 1gm POD
Current Illness:
Preexisting Conditions: rheumatoid arthritis, fibromyalgia, essential tremors, unspecified cardiac arrhythmia, anxiety
Allergies:
Diagnostic Lab Data: White Blood Count | 21.42 | H | 3.98-10.04 10^3/uL | | RECHECKED | | Red Blood Count | 3.29 | L | 3.93-5.22 10^6/uL | Hemoglobin | 11.00 | L | 11.2-15.7 g/dL | Hematocrit | 34.10 | | 34.1-44.9 % | Mean Corpuscular Volume | 103.6 | H | 79.0-94.8 fL | Mean Corpuscular Hemoglobin | 33.4 | H | 25.6-32.2 pg | Mean Corpuscular HGB Conc | 32.3 | | 32.2-36.5 g/dL | RDW Standard Deviation | 57.3 | H | 35.1-46.3 fL | RDW Coefficient of Variation | 14.9 | H | 11.6-14.4 % | Platelet Count | 52 | L | 163-369 10^3/uL | | RECHECKED | RESULTS CALLED TO RN AT 0326 BY MT | | PLATELETS ESTIMATED BY SMEAR | 2-10 PLTS/FIELD Mean Platelet Volume | 12.1 | | 9.4-12.4 fL | Neutrophils Percent Auto | 93.2 | H | 34.0-71.1 | Lymphocytes Percent Auto | 4.1 | L | 19.3-53.1 | Monocytes Percent Auto | 1.5 | L | 4.7-12.5 % | Eosinophils Percent Auto | 0.0 | L | 0.7-7.0 % | Basophils Percent Auto | 0.5 | | 0.1-1.2 % | Immature Granulocyte | 0.7 | H | 0.0-0.4 % | Neutrophils Absolute Auto | 19.96 | H | 1.56-6.13 10^3/uL | Lymphocytes Absolute Auto | 0.88 | L | 1.18-3.74 10^3/uL | Monocytes Absolute Auto | 0.32 | | 0.24-0.82 10^3/uL | Eosinophils Absolute Auto | 0.01 | L | 0.04-0.54 10^3/uL | Basophils Absolute Auto | 0.11 | H | 0.01-0.08 10^3/uL | Immature Granulocyte Absolute | 0.14 | H | 0.00-0.03 10^3/uL | Neutrophils Percent Manual | 68 | | 44-76 % | Band Neutrophils Percent | 16 | H | 2-6 % | Lymphocytes Percent Manual | 8 | L | 15-43 % | Monocytes Percent Manual | 8 | | 2-12 | Nucleated Red Blood Cells | 0.2 | | 0.0-1.0 % | Nucleated RBC Absolute | 0.04 | | 0.0-0.10 10^3/uL | Dohle Bodies | 1+ | | | PT/PTT COMBO Prothrombin Time | 16.90 | H | 9.5-12.0 sec | INR | 1.64 | H | 0.86-1.12 | Partial Thromboplastin Time | 42.50 | H | 24.0-33.0 sec | Sodium | 136 | | 136-145 mmol/L | Potassium | 3.20 | L | 3.50-5.10 mmol/L | Chloride | 100 | | 98-107 mmol/L | Carbon Dioxide | 13.00 | L | 21.00-32.00 mmol/L | Anion Gap | 23.00 | H | 10-20 | Blood Urea Nitrogen | 66.00 | H | 7.00-18.00 mg/dL | Creatinine | 4.53 | H | 0.6-1.30 mg/dL | Estimated Glomerular Filt Rate | 10.2 | | | | Reference Values: Greater than 60.0 mL/min/1.73 sqm. | Please multiply de GFR result by 1.210 in case of patients | who are African American. The IDMS-Traceable MDRD Study | Equation is applied to patients who are 18 year or older. | The MDRD Study equation has not been tested in children, the | elderly (over 70 years of age), pregnant women, patients | with serious comorbid conditions, or person with extremes of | body size, muscle mass or nutritional status. BUN Creatinine Ratio | 14.6 | | 12.0-20.0 mg/dL | Pharmacy Creatinine | 16.389 | | | Glucose | 221 | H | 74-106 mg/dL | Osmolality Calculated| 298.10 | H | 275.00-295.00 mmol/L | Calcium | 8.1 | L | 8.5-10.1 mg/dL | Total Bilirubin | 1.10 | H | 0.2-1.0 mg/dL | Direct Bilirubin | 0.80 | H | 0.0-0.3 mg/dL | Indirect Bilirubin | 0.30 | | 0.20-1.20 mg/dL | Gamma Glutamyl Transpeptidase | 86 | H | 5-55 U/L | Aspartate Amino Transferase | 121 | H | 15-37 U/L | Alanine Aminotransferase | 43 | | 12-78 U/L | Lactate Dehydrogenase| 672 | H | 84-246 U/L | Total Protein | 6.2 | L | 6.4-8.2 g/dL | Albumin | 3.6 | | 3.4-5.0 g/dL | Globulin | 2.6 | | 2.3-3.5 g/dL | Albumin Globulin Ratio | 1.38 | L | 1.50-2.2 g/dL | Cholesterol | 96 | | 0-240 mg/dL | | Reference Ranges: | | 2-17 years | Desirable: <170 mg/dL | Borderline High: 170-199 mg/dL | High: $g=200 mg/dL | | 18 years or Older | Desirable: <200 mg/dL | Bordeline High: 200-239 mg/dL | High: $g=240 mg/dL Alkaline Phosphatase | 241 | H | 42-117 U/L | Amylase | 74.00 | | 25.00-115.00 U/L | Lipase | 32 | | 12-53 U/L | | New reference range for Atellica Method.
CDC Split Type:

Write-up: Sepsis, Acute Pancreatitis, Respiratory Failure on Mechanical Ventilation, Disseminated Intravascular Coagulation, Pneumonia, Acute Kidney Injury. Refractory Hypoglycemia


VAERS ID: 986631 (history)  
Form: Version 2.0  
Age: 87.0  
Sex: Female  
Location: Michigan  
Vaccinated:2021-01-14
Onset:2021-01-15
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-01-29
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA - / 1 AR / SYR

Administered by: Senior Living       Purchased by: ?
Symptoms: Death, Myocardial infarction
SMQs:, Myocardial infarction (narrow), Embolic and thrombotic events, arterial (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Hypertension, hyperthyroidism
Allergies: No known allergies.
Diagnostic Lab Data:
CDC Split Type:

Write-up: Suspected myocardial infarction on 01/15/2021. Patient passed away on 01/15/2021.


VAERS ID: 986636 (history)  
Form: Version 2.0  
Age: 80.0  
Sex: Male  
Location: Missouri  
Vaccinated:2021-01-28
Onset:2021-01-28
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-01-29
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 004MZ0A / 1 LA / IM

Administered by: Pharmacy       Purchased by: ?
Symptoms: Cardiac disorder, Myocardial infarction
SMQs:, Myocardial infarction (narrow), Embolic and thrombotic events, arterial (narrow)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness: Unknown
Preexisting Conditions: Unknown
Allergies: None Reported
Diagnostic Lab Data:
CDC Split Type:

Write-up: Patient waited 15 minutes after injection at the vaccine clinic. Shortly after leaving the clinic (less than 1 hour), the patient was taken by ambulance to the hospital experiencing cardiac issues. Patient was air-lifted to larger hospital and later diagnosed with myocardial infarction.


VAERS ID: 987979 (history)  
Form: Version 2.0  
Age: 80.0  
Sex: Female  
Location: Wisconsin  
Vaccinated:2021-01-11
Onset:2021-01-18
   Days after vaccination:7
Submitted: 0000-00-00
Entered: 2021-01-30
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 011L20A / 1 - / IM

Administered by: Private       Purchased by: ?
Symptoms: Injection site pruritus, Injection site reaction, Petechiae, Rash erythematous
SMQs:, Anaphylactic reaction (broad), Haemorrhage terms (excl laboratory terms) (narrow), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Tylenol #3, amlodipine, fenofibrate, vitamin D
Current Illness:
Preexisting Conditions: osteoporosis, pernicious anemia
Allergies: iodine contrast media, tetracycline
Diagnostic Lab Data: none
CDC Split Type:

Write-up: Flat red rash approximately 3 inches in diameter surrounding injection site (looked like petechiae) with extreme itching for 2-3 days. Notified appropriate local site to report reaction. No more symptoms after 3 days. Unknown if caused by the Covid vaccine as it occurred 8 days after injection.


VAERS ID: 988061 (history)  
Form: Version 2.0  
Age: 82.0  
Sex: Male  
Location: Michigan  
Vaccinated:2021-01-11
Onset:2021-01-11
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-01-30
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA - / 1 - / -

Administered by: Private       Purchased by: ?
Symptoms: Acute respiratory distress syndrome, C-reactive protein, Chest X-ray abnormal, Chills, Computerised tomogram thorax abnormal, Fatigue, Fibrin D dimer increased, Intensive care, Lactic acidosis, Lung opacity, Procalcitonin, Pulmonary congestion, Pulmonary embolism, Pulmonary oedema, Pyrexia, Respiratory tract congestion, Troponin, White blood cell count
SMQs:, Cardiac failure (narrow), Lactic acidosis (narrow), Haemorrhage laboratory terms (broad), Hyperglycaemia/new onset diabetes mellitus (broad), Interstitial lung disease (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Embolic and thrombotic events, venous (narrow), Guillain-Barre syndrome (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Cardiomyopathy (broad), Eosinophilic pneumonia (broad), Respiratory failure (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (broad)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Moduretic, ASA 81mg, glipizide, losartan, metformin, potassium chloride, potassium citrate
Current Illness: None
Preexisting Conditions: CKD stage 2, DM2, essential hypertension, hyperlipidemia, obesity (BMI 27.3)
Allergies: None
Diagnostic Lab Data: Labs- elevated d diner, troponin, procalcitonin, lactic acidosis, c reactive protein, white blood cells. chest X-rays- ground glass, pulmonary edema and congestion. ct scan- positive for pulmonary emboli and ground glass
CDC Split Type:

Write-up: Chills, fever, fatigue from day of onset. Currently in ICU for ARDS


VAERS ID: 988302 (history)  
Form: Version 2.0  
Age: 41.0  
Sex: Female  
Location: Texas  
Vaccinated:2021-01-01
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-01-30
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA - / 1 RA / IM

Administered by: Unknown       Purchased by: ?
Symptoms: Heavy menstrual bleeding, Thrombosis
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Stelara
Current Illness:
Preexisting Conditions: Psoriatic Arthritis
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Very heavy period. Passed multiple golf ball sized clots for several hours.


VAERS ID: 988325 (history)  
Form: Version 2.0  
Age: 60.0  
Sex: Female  
Location: Michigan  
Vaccinated:2021-01-06
Onset:2021-01-26
   Days after vaccination:20
Submitted: 0000-00-00
Entered: 2021-01-30
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 025L20A / 1 LA / IM

Administered by: Private       Purchased by: ?
Symptoms: Biopsy skin, Petechiae, Purpura, Rash, Type III immune complex mediated reaction, Vasculitis
SMQs:, Anaphylactic reaction (broad), Haemorrhage terms (excl laboratory terms) (narrow), Vasculitis (narrow), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 3 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Hydrochlorothiazide last taken 2 weeks prior to vaccine administration Levothyroxine Albuterol as needed Daily multivitamin
Current Illness: None.
Preexisting Conditions: Anxiety, HLD, HTN, hypothyroidism, rosacea, liver steatosis secondary to obesity Migraine, impaired fasting glucose without diagnosis of T2DM, obesity with BMI 40.5
Allergies: Codeine and morphine intolerance Sulfa antibiotics-prior hives seen on administration in her 20s
Diagnostic Lab Data: Punch biopsy of rash with result pending at time of report.
CDC Split Type:

Write-up: Onset of Petechial/purpural rash along BLE starting in thighs B/L with spread to abdomen and BUE. Probable Type III Hypersensitivity vs vasculitis. Came to hospital 01/28/2021. Treated with PO steroids 60 mg PO prednisone with rapid improvement. Testing still pending.


Result pages: prev   1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19   next

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=10&SYMPTOMS[]=Cerebral_venous_sinus_thrombosis_%2810083037%29&SYMPTOMS[]=Cerebral_venous_thrombosis_%2810008138%29&SYMPTOMS[]=Coagulopathy_%2810009802%29&SYMPTOMS[]=Deep_vein_thrombosis_%2810051055%29&SYMPTOMS[]=Disseminated_intravascular_coagulation_%2810013442%29&SYMPTOMS[]=Embolism_%2810061169%29&SYMPTOMS[]=Idiopathic_thrombocytopenic_purpura_%2810021245%29&SYMPTOMS[]=Immune_thrombocytopenia_%2810083842%29&SYMPTOMS[]=Immune_thrombocytopenic_purpura_%2810074667%29&SYMPTOMS[]=Ischaemic_stroke_%2810061256%29&SYMPTOMS[]=Myocardial_infarction_%2810028596%29&SYMPTOMS[]=Petechiae_%2810034754%29&SYMPTOMS[]=Pulmonary_embolism_%2810037377%29&SYMPTOMS[]=Purpura_%2810037549%29&SYMPTOMS[]=Thrombocytopenia_%2810043554%29&SYMPTOMS[]=Thrombosis_%2810043607%29&SYMPTOMS[]=Vasculitis_%2810047115%29&VAX=COVID19&VAXMAN=MODERNA


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166